XML 60 R23.htm IDEA: XBRL DOCUMENT
v3.23.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Stock-Based Compensation | Stock-Based Compensation Total stock-based compensation expense consists of the following:
| Years Ended 31 March
(Millions of US dollars) | 2023 |  | 2022 |  | 2021
Liability Awards | $ | 2.7 |  |  | $ | 3.2 |  |  | $ | 21.7 |
Equity Awards | 15.7 |  |  | 9.0 |  |  | 18.0 |
Total stock-based compensation expense | $ | 18.4 |  |  | $ | 12.2 |  |  | $ | 39.7 |
As of 31 March 2023, the unrecorded future stock-based compensation expense related to outstanding equity awards was US$30.6 million and will be recognized over an estimated weighted average amortization period of 1.9 years. 2001 Equity Incentive Plan Under the Company’s 2001 Equity Incentive Plan (the “2001 Plan”), which was amended and restated in August 2021 and approved by shareholders, the Company can grant equity awards in the form of nonqualified stock options, performance awards, restricted stock grants, stock appreciation rights, dividend equivalent rights, phantom stock or other stock-based benefits such as restricted stock units. Long-Term Incentive Plan 2006 The Company’s shareholders approved the establishment of a Long-Term Incentive Plan in 2006 (the “LTIP”) to provide incentives to certain members of senior management (“Executives”). The Company determines the conditions or restrictions of any awards, which may include requirements of continued employment, individual performance or the Company’s financial performance or other criteria. Currently, the plan only allows for RSUs to be granted under the LTIP. The following table summarizes the Company’s shares available for grant as options, RSUs or other equity instruments under the LTIP and 2001 Plan:
| Shares Available for Grant
Balance at 31 March 2021 | 22,087,623 |
Granted | (597,927) |
Balance at 31 March 2022 | 21,489,696 |
Granted | (2,540,893) |
Balance at 31 March 2023 | 18,948,803 |
Stock Options There were no stock options granted during the years ended 31 March 2022 or 2021. The following table summarizes the Company's stock options activity during the noted period:
|  | Outstanding Options
|  | Number of Options |  | Weighted Average Exercise Price (A$)
Balance at 31 March 2022 |  | — |  |  | — |
Granted |  | 269,221 |  |  | 33.05 |
Balance at 31 March 2023 |  | 269,221 |  |  | 33.05 |
Options exercisable at 31 March 2023 |  | — |  |  | — |
Stock options vest on the third anniversary of the date of grant provided continuous employment at the applicable vesting date. Vested stock options can be exercised for shares for the exercise price at any time. As of 31 March 2023, the weighted-average remaining contractual term is 4.6 years and the aggregate intrinsic value is nil. RSUs The Company estimates the fair value of RSUs on the date of grant and recognizes this estimated fair value as compensation expense over the periods in which the RSU vests. The following table summarizes the Company’s RSU activity:
(Units) | Service Vesting (2001 Plan) |  | Performance Vesting (LTIP) |  | Market Conditions (LTIP) |  | Total |  | Weighted Average Fair Value at Grant Date (A$)
Outstanding at 31 March 2021 | 593,486 |  |  | 726,288 |  |  | 1,286,922 |  |  | 2,606,696 |  |  | 19.01 |
Granted | 233,443 |  |  | 141,015 |  |  | 223,469 |  |  | 597,927 |  |  | 41.73 |
Vested | (313,641) |  |  | (248,202) |  |  | (565,878) |  |  | (1,127,721) |  |  | 14.96 |
Forfeited | (98,613) |  |  | (327,397) |  |  | (450,480) |  |  | (876,490) |  |  | 27.73 |
Outstanding at 31 March 2022 | 414,675 |  |  | 291,704 |  |  | 494,033 |  |  | 1,200,412 |  |  | 27.83 |
Granted | 1,279,127 |  |  | 268,009 |  |  | 724,536 |  |  | 2,271,672 |  |  | 26.12 |
Vested | (449,458) |  |  | (87,307) |  |  | (256,787) |  |  | (793,552) |  |  | 25.17 |
Forfeited | (107,818) |  |  | (100,377) |  |  | (91,738) |  |  | (299,933) |  |  | 28.46 |
Outstanding at 31 March 2023 | 1,136,526 |  |  | 372,029 |  |  | 870,044 |  |  | 2,378,599 |  |  | 26.97 |
The following table includes the assumptions used for RSU grants (market condition) valued:
Vesting Condition: | Market |  | Market |  | Market |  | Market |  | Market |  | Market |  | Market |  | Market
| FY23 |  | FY23 |  | FY23 |  | FY23 |  | FY23 |  | FY23 |  | FY22 |  | FY22
Date of grant | 31-Aug-22 |  | 31-Aug-22 |  | 3-Nov-22 |  | 3-Nov-22 |  | 3-Nov-22 |  | 13-Mar-23 |  | 27-Aug-21 |  | 9-Sep-21
Dividend yield (per annum) | 1.5 | % |  | 1.5 | % |  | — | % |  | — | % |  | — | % |  | — | % |  | 2.0 | % |  | 2.0 | %
Expected volatility | 41.9 | % |  | 33.4 | % |  | 42.5 | % |  | 35.1 | % |  | 43.8 | % |  | 36.3 | % |  | 40.0 | % |  | 40.2 | %
Risk free interest rate | 3.5 | % |  | 3.5 | % |  | 4.7 | % |  | 4.7 | % |  | 4.7 | % |  | 4.0 | % |  | 0.4 | % |  | 0.4 | %
Expected life in years | 3.0 |  | 2.0 |  | 0.8 |  | 1.8 |  | 2.8 |  | 2.4 |  | 3.0 |  | 2.9
JHX stock price at grant date (A$) | 33.51 |  | 33.51 |  | 33.05 |  | 33.05 |  | 33.05 |  | 30.98 |  | 52.66 |  | 52.12
Number of restricted stock units | 387,360 |  | 102,250 |  | 38,387 |  | 39,450 |  | 115,688 |  | 41,401 |  | 130,513 |  | 92,956
The following table presents the total fair value of all of our restricted stock units vested:
|  | Years ended 31 March
(Millions of US dollars) |  | 2023 |  | 2022 |  | 2021
Total fair value vested |  | $ | 18.4 |  |  | $ | 42.6 |  |  | $ | 27.8 |
Scorecard LTI – CSUs Under the terms of the LTIP, the Company grants scorecard LTI CSUs to executives and the vesting of awards is based on the individual's performance measured over a three year period against certain performance targets. These awards provide recipients a cash incentive based on an average 20 trading-day closing price of JHI plc’s common stock price and each executive’s scorecard rating. The following represents the activity related to the CSUs:
|  | FY23 |  | FY22
Granted |  | 751,569 |  |  | 423,051 |
Vested |  | 237,600 |  |  | 433,872 |
Cancelled |  | 325,459 |  |  | 1,292,934 |
For the fiscal years ending 31 March 2023, 2022 and 2021, US$5.9 million, US$15.2 million and US$8.2 million, respectively, was paid in cash upon vesting of CSU units.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration